Brief: Rhythm Biosciences Sats Significant Cost Reduction Program Continues
16/02/2024 01:31
Feb 16 (Reuters) - Rhythm Biosciences Ltd RHY.AX :
* SIGNIFICANT COST REDUCTION PROGRAM CONTINUES, WITH ONGOING
CASH-BURN MARKEDLY REDUCED
Source text for Eikon: ID:nASX9snP2C
Further company coverage: RHY.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Rhythm Biosciences
See all newsBrief: Rhythm Biosciences Says Gavin Fox-Smith Resigns As Chair
Brief: Rhythm Biosciences Announces Appointment Of Non-Executive Directors
Australia's Rhythm Biosciences rises on accelerating commercialisation of cancer test
Brief: Rhythm Biosciences Executes Distribution Agreement For Genetype
Brief: Rhythm Biosciences Seeks Trading Halt